Credit: Technology ReviewFrom Technology Review:
A startup aims to calculate the value in the onslaught of genetic tests.
Per Lofberg wants to bring genomic medicine to the masses by overcoming one of the field's biggest barriers--getting insurers and other payers to cover the growing numbers of genetic tests reaching the market. To achieve that, he founded Generation Health, a health benefit management company that aims to sift through the data on these tests, which range from those that predict an individual's risk of heart disease or cancer to those that determine how well a patient metabolizes a certain drug. Lofberg's goal is to find the ones that provide the greatest medical utility and economic value.
Read more ....
No comments:
Post a Comment